STOCK TITAN

Integra Lifesciences (NASDAQ: IART) SVP uses 937 shares for tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

INTEGRA LIFESCIENCES HOLDINGS CORP senior vice president and principal accounting officer Jeffrey Mosebrook reported a tax-related share disposition. On this Form 4, 937 shares of common stock were delivered at $17.89 per share to satisfy tax obligations, leaving him with 34,516 directly held shares.

Positive

  • None.

Negative

  • None.
Insider Mosebrook Jeffrey
Role SVP, Fin & Princ Acct Officer
Type Security Shares Price Value
Tax Withholding Common Stock 937 $17.89 $17K
Holdings After Transaction: Common Stock — 34,516 shares (Direct)
Footnotes (1)
Tax-withholding shares 937 shares Common stock delivered for tax liability on 2026-07-01
Transaction price $17.89 per share Value assigned to tax-withholding disposition
Shares owned after transaction 34,516 shares Direct common stock holdings following Form 4 event
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
transaction code "F" regulatory
"transaction_code: "F" with description of tax liability payment"
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Payment of exercise price or tax liability by delivering securities regulatory
"transaction_code_description: "Payment of exercise price or tax liability by delivering securities""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did INTEGRA LIFESCIENCES (IART) report for Jeffrey Mosebrook?

Jeffrey Mosebrook reported a tax-related share disposition of 937 common shares. The shares were delivered to cover obligations described as payment of exercise price or tax liability, rather than an open-market sale, under his Form 4 filing.

Was the IART insider transaction a buy or sell of common stock?

The filing records a disposition of 937 shares for tax withholding purposes. It is coded as an “F” transaction, meaning shares were delivered to pay an exercise price or tax liability, not a discretionary open-market purchase or sale.

How many INTEGRA LIFESCIENCES (IART) shares does Jeffrey Mosebrook hold after the transaction?

After the tax-withholding disposition, Jeffrey Mosebrook directly holds 34,516 shares of INTEGRA LIFESCIENCES common stock. This post-transaction balance reflects his remaining direct ownership reported in the Form 4 filing.

What was the price used for the tax-withholding shares in the IART Form 4?

The 937 shares used for tax withholding were valued at $17.89 per share. This price is reported in the Form 4 as the transaction price per share associated with the tax-liability payment.

What does transaction code "F" mean in the IART insider filing?

Transaction code “F” indicates payment of an exercise price or tax liability by delivering securities. In this IART filing, 937 shares of common stock were disposed of to satisfy such obligations, rather than being sold in the open market.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mosebrook Jeffrey

(Last)(First)(Middle)
1100 CAMPUS ROAD

(Street)
PRINCETON NEW JERSEY 08540

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Fin & Princ Acct Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026F937D$17.8934,516D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Lesha Shinn; Attorney-in-Fact for Jeffrey Mosebrook07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)